robbie schreef:
Citaat:
k kan dit echter weer niet rijmen met de resultaten van Buffalo: 55 - 65 %. Ik kan bijna niet anders denken dan aan foutieve metingen/instellingen apparatuur in de beginperiode (wat al sommigen al suggeerden)
Willem, ik heb ergens proberen uit te leggen dat de Buffalo resultaten helemaal niet tegenvallen.
Zamboni had alleen patiente met jaren CDMS
Buffalo heeft veel meer groepen genomen, kinderen, recente/lange diagnose.
Ik gok er op dat de groep met het Zambonie 'profiel' veel hoge scoort.
Robert
Loopt hierover een draad op Tims. In de canadese pers worden andere getallen genoemd - te weten ccsvi aangetroffen bij 37% van de CIS gevallen en bij 80% CDMS. Er is contact geweest met de betreffende journalist heeft bevestigd dat dit de cijfers zijn zoals Dr Zivadinov ze zelf heeft genoemd.
http://www.thisisms.com/ftopic-10255-0.htmlCitaat:
what was reported in the Canadian Press was that, while the incidence of CCSVI in ALL MS patients was 55% (as the BNAC press release said), Zivadinov indicated that it was 80% in Clinically Diagnosed MSers. So nothing has changed from what has been discussed in other threads: while the incidence of CCSVI MAY be 55% (or 65%, depending how you count it) for some sort of broadly defined category of MSer (and we don't know how that was defined) it is 80% for people who have been clinically diagnosed.
Citaat:
Folks, I've just received an e-mail from the Canadian Press medical reporter. The statistics she reported (38% for CIS, 80% for CDMS) were NOT in the BNAC press release - they came from her interview with Zivadinov. I know that these numbers are still causing some debate and head-scratching, but at least you should know that it isn't the result of calculations done by an over-eager, mathematically-challenged reporter: they came from the horse's mouth.
http://www.google.com/hostednews/canadi ... lWEAgfVkvw http://www.winnipegfreepress.com/life/h ... Comments=y http://www.healthzone.ca/health/newsfea ... f-ms-study